---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/275657966.md"
description: "Vanda Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q4 financial results and issued FY26 sales guidance below estimates."
datetime: "2026-02-11T21:04:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275657966.md)
  - [en](https://longbridge.com/en/news/275657966.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275657966.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/275657966.md) | [繁體中文](https://longbridge.com/zh-HK/news/275657966.md)


# 

Vanda Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q4 financial results and issued FY26 sales guidance below estimates.

### Related Stocks

- [iShares US Pharmaceuticals ETF (IHE.US)](https://longbridge.com/en/quote/IHE.US.md)
- [First Trust NYSE Arca Biotech ETF (FBT.US)](https://longbridge.com/en/quote/FBT.US.md)
- [ALPS Medical Breakthroughs ETF (SBIO.US)](https://longbridge.com/en/quote/SBIO.US.md)
- [VanEck Biotech ETF (BBH.US)](https://longbridge.com/en/quote/BBH.US.md)
- [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/en/quote/IBB.US.md)
- [Vanda Pharmaceuticals Inc. (VNDA.US)](https://longbridge.com/en/quote/VNDA.US.md)
- [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/en/quote/PBE.US.md)
- [State Street®HlthCrSelSectSPDR®ETF (XLV.US)](https://longbridge.com/en/quote/XLV.US.md)
- [State Street® SPDR® S&P® Biotech ETF (XBI.US)](https://longbridge.com/en/quote/XBI.US.md)
- [Vanguard Health Care ETF (VHT.US)](https://longbridge.com/en/quote/VHT.US.md)

## Related News & Research

- [ACADIA Pharmaceuticals Maps Key CNS Readouts: Remlifanserin ADP Data Due Aug–Oct, ACP-211 Next Year](https://longbridge.com/en/news/279474943.md)
- [Mirum Pharmaceuticals Executives Sell Shares](https://longbridge.com/en/news/279503772.md)
- [Big drugmakers must face US overcharge claims on medications for low-income patients](https://longbridge.com/en/news/279476055.md)
- [19:00 ETBreakthrough at 2026 AACR! Senhwa Biosciences' CX-5461 Enters the Field of Photodynamic Therapy, Opening a New Indication Strategy](https://longbridge.com/en/news/279500468.md)
- [Vanda Advances NEREUS Launch With Direct-to-Consumer Strategy](https://longbridge.com/en/news/278644625.md)